Erin Ellison
Nurse Practitioner · Bremen, GANPI 1669710786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $996, more than ten times the $51 reported in 2021.
Across 172 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$537
- Novo Nordisk$473
- Pfizer$237
- Astellas Pharma US Inc$162
- Lilly USA, LLC$144
- Novartis$139
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,806100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $537 |
| Novo Nordisk | 32 | $473 |
| Pfizer | 13 | $237 |
| Astellas Pharma US Inc | 7 | $162 |
| Lilly USA, LLC | 9 | $144 |
| Novartis | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 8 | $137 |
| Amgen | 8 | $118 |
| Lundbeck LLC | 6 | $102 |
| Shield Therapeutics Inc | 5 | $97 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| GSK | 4 | $73 |
| AstraZeneca | 4 | $72 |
| Sumitomo Pharma America, Inc. | 4 | $71 |
| Johnson & Johnson | 1 | $32 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $30 |
| Acella Pharmaceuticals, LLC | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Covis Pharma GmbH | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Mylan Specialty L.p. | 1 | $16 |
| Linus Health, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,806 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $38,910 |
| JardianceEmpagliflozin | 41 | $32,133 |
| FarxigaDapagliflozin Propanediol | 39 | $26,075 |
| EliquisApixaban | 21 | $18,943 |
| TrulicityDulaglutide | 20 | $18,411 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $10,340 |
| Levothyroxine Sodium | 138 | $1,160 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,153 |
| Armour ThyroidThyroid,pork | 25 | $923 |
| Atorvastatin Calcium | 168 | $872 |
| Duloxetine Hcl | 36 | $845 |
| Gabapentin | 62 | $722 |
| Aripiprazole | 28 | $644 |
| Quetiapine Fumarate | 18 | $504 |
| Escitalopram Oxalate | 54 | $476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $473 | $38,91033 claims |
| AstraZenecaFarxiga | $72 | $26,07539 claims |
| PfizerEliquis | $237 | $18,94321 claims |
| Lilly USA, LLCTrulicity | $144 | $18,41120 claims |
| GSKTrelegy Ellipta | $73 | $10,34014 claims |
| AbbVieArmour Thyroid | $537 | $92325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Bremen
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
- Luis PoloSavannah$70K
- Karen BauerDecatur$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.